Prostate Cancer with Bone Metastases: Addressing Chronic Pain from the Perspective of the Radiation Oncology Nurse Practitioner

被引：3
|
作者：
Pituskin, Edith [1 ]
Fairchild, Alysa [2 ]
机构：
[1] Univ Alberta, Fac Nursing, 3-141 Edmonton Clin Hlth Acad,11405-87 Ave NW, Edmonton, AB T6G 1C9, Canada
[2] Univ Alberta, Fac Med & Dent, Dept Radiat Oncol, Edmonton, AB, Canada
来源：
SEMINARS IN ONCOLOGY NURSING | 2021年 / 37卷 / 04期
关键词：
Bone metastases; Physical examination; Castrate-resistant prostate cancer; Pain relief; Symptom assessment; Palliative radiotherapy; PALLIATIVE RADIOTHERAPY TRIALS; FINANCIAL TOXICITY; PATIENT;
D O I：
10.1016/j.soncn.2021.151175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objectives: To discuss the symptom burden experienced among patients with castrate-resistant prostate cancer and bone metastases and the role of the oncology nurse practitioner in evaluation for palliative radiotherapy. Data Sources: These include PubMed, international consensus documents, and clinician experience. Conclusion: Men with advanced prostate cancer may live for several years after diagnosis of bone metastases; however, pain and other difficult symptoms are problematic. Pain is effectively treated with palliative radiotherapy, but careful assessment and intervention of other difficult symptoms must be addressed over time. Implications for Nursing Practice: Nurse practitioners in radiation oncology should be well-versed in the disease trajectory of this patient population. Careful symptom inquiry and comprehensive physical examination is a key responsibility. Palliative radiotherapy, alongside analgesics and supportive care measures, can effectively reduce symptoms and improve quality of life in men with prostate cancer metastatic to bone. (c) 2021 Published by Elsevier Inc.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Radioisotopic treatment of bone pain from metastatic prostate cancer
    Oliver Sartor
    Current Oncology Reports, 2003, 5 (3) : 258 - 262
  • [42] PAIN FROM BONE METASTASES AS THE ADMITTING COMPLAINT IN CERVICAL-CANCER
    EVANS, WF
    GRAHAM, JE
    BUCHSBAUM, HJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1983, 145 (06) : 765 - 766
  • [43] Use of zoledronic acid in patients with prostate cancer bone metastases: control of pain and musculoskeletal complications
    Paparella, Stefano
    Finkelberg, Elisabetta
    Varisco, Daniela
    Tondelli, Elena
    Rocco, Francesco
    UROLOGIA JOURNAL, 2011, 78 (04) : 300 - 304
  • [44] Stereotactic Body Versus Hypofractionated Radiation Therapy for Local Control of Prostate Cancer Bone Metastases
    Gao, R. W.
    Olivier, K.
    Park, S. S.
    Davis, B. J.
    Choo, C. R.
    Pisansky, T. M.
    Karnes, R. J.
    Kwon, E. D.
    Stish, B. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S108 - S108
  • [45] Oncology patients' perception of the quality of nurse practitioner care during an audit and feedback intervention to implement clinical practice guidelines for cancer pain
    Dulko, Dorothy
    Bacik, Jennifer
    Hertz, Elisheva
    Julien, Jerelyn
    Mooney, Kathleen
    ONCOLOGY NURSING FORUM, 2008, 35 (03) : 491 - 491
  • [46] Can Breast Cancer Receptor Status Predict Pain Response in Palliative Radiation for Bone Metastases?
    Sit, D.
    Zhao, B.
    Chen, K. T.
    Speers, C.
    Lohrisch, C.
    Olson, R. A.
    Nichol, A.
    Hsu, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E162 - E162
  • [47] Predictors of clinical outcome in patients with bone metastases from prostate cancer.
    Saad, F.
    Coleman, R. E.
    Cook, R.
    Smith, M. R.
    Brown, J. E.
    Hei, J. Y.
    Chen, Y. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 230S - 230S
  • [48] Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey
    Hutton, Brian
    Morretto, Patricia
    Emmenegger, Urban
    Mazzarello, Sasha
    Kuchuk, Iryna
    Addison, Christina L.
    Crawley, Freya
    Canil, Christine
    Malone, Shawn
    Berry, Scott
    Fergusson, Dean
    Clemons, Mark
    JOURNAL OF BONE ONCOLOGY, 2013, 2 (03): : 105 - 109
  • [49] Zoledronic acid provides long-term reduction of bone pain in patients with bone metastases secondary to prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 144 - 144
  • [50] Investigating the Underlying Molecular Mechanisms of Yunke on Bone Metastases from Prostate Cancer
    Liu, Simin
    Tian, Zhiyuan
    Zhang, Taiming
    Zhang, Jirong
    Huo, Yanlei
    Ma, Chao
    BIOLOGICS-TARGETS & THERAPY, 2024, 18 : 195 - 206
12345